UCLH has recruited the first participant to a global study of a new drug in early development, which is thought to reduce the production of a protein in the brain called tau.
A new CAR-T therapy has delivered promising results in treating patients with an aggressive blood cancer, in results from a trial led by researchers at UCL and UCLH.
UCL researchers will co-lead a new initiative to reduce maternity inequalities by improving care and support for families before and between pregnancies.
We caught up with Dr Samer Elkhodair, whose team within the emergency department is expanding its research thanks to funding from the UCLH Research Directorate.
Three patients in the UK have received an innovative treatment for the most serious form of lupus – an autoimmune condition which can cause damage to the heart, lungs, joints, brain or kidneys.
Care for stroke survivors urgently needs to focus on non-motor outcomes like fatigue, anxiety and reduced social participation, according to a new UCLH and UCL study.
